DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B Share Price

Certificat

DE000MG1C9S6

Real-time Bid/Ask 16:22:37 03/07/2024 BST
79.67 EUR / 79.71 EUR -0.85% Intraday chart for DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B
Current month-0.07%
1 month+1.93%
Date Price Change
03/07/24 80.05 -0.40%
02/07/24 80.37 -0.20%
01/07/24 80.53 +0.12%
28/06/24 80.43 -0.12%
27/06/24 80.53 -0.21%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 11:36 am

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying NOVO NORDISK A/S
Issuer Morgan Stanley
WKN MG1C9S
ISINDE000MG1C9S6
Date issued 02/04/2024
Cap 90 $
Last trading day 21/03/2025
Maturity 21/03/2025 (261 Days)
Parity 1 : 1
Emission price 78.23
Emission volume N/A
Payment day 28/03/2025
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 37.77 %
Sideways yield 4.493 %
Sideways yield pa 6.284 %
Outperformance point 144.6 $
Break even 86.13 €
Highest since issue 80.7
Lowest since issue 76.66
Spread 0.06
Spread %0.08%
Distance Cap 47.18 $
Distance Cap %+34.39%
Max. earning 3.583
Max. earning % 4.493 %

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus